Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Nevro to Highlight Substantial Body of Clinical Evidence Supporting Expanded Applications and Unique Capabilities of HF10 Therapy at the 14th International Neuromodulation Society World Congress

SYDNEY, May 26, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced a series of data presentations supporting the use of the Company's HF10(TM) therapy for patients... Read more ››

By: PR Newswire Association LLC. - 26 May 2019
Related companies:  Nevro Corp.

Cambridge Medical and Rehabilitation Center (CMRC) Admits First Patients to Its New Saudi Facility

RIYADH, Saudi Arabia, May 26, 2019 /PRNewswire/ -- Cambridge Medical and Rehabilitation Center (CMRC), a top post-acute rehabilitation and long-term care facility in the UAE, has admitted 15 patients to its newly opened medical facility in Saudi Arabia. CMRC's new 60-bed clinic, located between... Read more ››

By: PR Newswire Association LLC. - 26 May 2019

Desert Hope Treatment Center Welcomes Dee Wirth as Alumni Manager

LAS VEGAS, May 26, 2019 /PRNewswire/ -- The concept of camaraderie is essential in addiction recovery, which is why American Addiction Centers (NYSE: AAC) created an alumni program that expands the entire country. Based on her own experience with addiction, Dee Wirth, alumni manager at Desert... Read more ››

By: PR Newswire Association LLC. - 26 May 2019

Heritage Pharmaceuticals Inc. Issues Voluntary Nationwide Recall of Amikacin Sulfate Injection, USP 1gm/4 mL (250mg/mL) and Prochlorperazine Edisylate Injection, USP 10mg/2mL (5mg/mL) as a result of a sterility test failure

EAST BRUNSWICK, N.J., May 25, 2019 /PRNewswire/ -- Heritage Pharmaceuticals Inc. ("Heritage") East Brunswick, New Jersey, is initiating a voluntary recall of Amikacin Sulfate Injection, USP, 1g/4 mL (250mg/mL), Lot: VEAC025, Expiry Date: October 2019 and Prochlorperazine Edisylate Injection,... Read more ››

By: PR Newswire Association LLC. - 25 May 2019
Related companies:  Heritage Pharmaceuticals Inc.

BOAZ Pharmaceuticals Inc. Celebrates Sales Licence Granted In Record Time

Read more ››
By: Nasdaq / GlobenewsWire - 25 May 2019

MDA Celebrates FDA Approval of Zolgensma for Treatment of Spinal Muscular Atrophy in Pediatric Patients

NEW YORK, May 24, 2019 /PRNewswire/ -- The Muscular Dystrophy Association (MDA) today celebrated the decision by the U.S. Food and Drug Administration (FDA) to grant approval of Zolgensma (onasemnogene abeparvovac-xioi), the first gene therapy for a neuromuscular disease. Zolgensma is a one-time... Read more ››

By: PR Newswire Association LLC. - 25 May 2019

Medtronic Chairman and CEO Omar Ishrak to Speak at Bernstein Strategic Decisions Conference

Read more ››
By: Nasdaq / GlobenewsWire - 24 May 2019
Related companies:  Medtronic Plc

HEXO Corp and Newstrike Brands Ltd. Announce Closing of Arrangement

Read more ››
By: Nasdaq / GlobenewsWire - 24 May 2019

HTG Molecular Diagnostics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: Nasdaq / GlobenewsWire - 24 May 2019
Related companies:  HTG Molecular Diagnostics, Inc.

Myovant Sciences Provides Corporate Updates and Reports Financial Results for Fourth Fiscal Quarter and Full Fiscal Year Ended March 31, 2019

Read more ››
By: Nasdaq / GlobenewsWire - 24 May 2019
Related companies:  Myovant Sciences, Inc.

Alder BioPharmaceuticals® Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: Nasdaq / GlobenewsWire - 24 May 2019
Related companies:  Alder BioPharmaceuticals, Inc.

DBV Technologies Announces Results of its 2019 Ordinary and Extraordinary General Meeting and the Appointment of Viviane Monges to the Board of Directors

Read more ››
By: Nasdaq / GlobenewsWire - 24 May 2019
Related companies:  DBV Technologies S.A.

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: Nasdaq / GlobenewsWire - 24 May 2019
Related companies:  Apellis Pharmaceuticals, Inc.

Aptose Biosciences Establishes New At-The-Market Facility

Read more ››
By: Nasdaq / GlobenewsWire - 24 May 2019
Related companies:  Aptose Biosciences Inc.

Allergan Announces Updated Presentation Time at the Bernstein Strategic Decisions Conference

DUBLIN, May 24, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that Chairman and CEO Brent Saunders will participate in a fireside chat at the Bernstein 35(th) Annual Strategic Decisions Conference in New York, NY. The presentation will begin at 4:00 p.m. Eastern Time on Thursday,... Read more ››

By: PR Newswire Association LLC. - 24 May 2019
Related companies:  Allergan plc

Central Nervous System Diseases Drug Delivery Markets, 2028

DUBLIN, May 24, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 24 May 2019

Blue Cross Blue Shield of Massachusetts Releases Statement on Trump Administration's Proposed Rollback of Transgender Health Care Accommodations

BOSTON, May 24, 2019 /PRNewswire/ -- In response to the Trump Administration's proposal to eliminate health care protections for transgender people, Andrew Dreyfus, president & CEO of Blue Cross Blue Shield of Massachusetts, released the following statement:

Read more ››
By: PR Newswire Association LLC. - 24 May 2019

Cardiovascular Drug Delivery Markets, 2028

DUBLIN, May 24, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 24 May 2019

FDA approves first PI3K inhibitor for breast cancer

SILVER SPRING, Md., May 24, 2019 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Piqray (alpelisib) tablets, to be used in combination with the FDA-approved endocrine therapy fulvestrant, to treat postmenopausal women, and men, with hormone receptor (HR)-positive, human... Read more ››

By: PR Newswire Association LLC. - 24 May 2019
Related companies:  U.S. Food and Drug Administration

Global Biomarkers Technologies, Markets, & Competitive Landscape to 2028 Featuring Profiles of 300+ Companies & 471 Collaborations

DUBLIN, May 24, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 24 May 2019
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑